Allergan plc
AGN.PRA
AGN.PRA was delisted on the 28th of February, 2018.
109 hedge funds and large institutions have $3.17B invested in Allergan plc in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 38 reducing their positions, and 8 closing their positions.
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
9% more capital invested
Capital invested by funds: $2.91B → $3.17B (+$258M)
3% more funds holding
Funds holding: 106 → 109 (+3)
16% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$86M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$70.5M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$65.7M |
| 4 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
+$58.9M |
| 5 |
ACM
Advent Capital Management
New York
|
+$54.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$175M |
| 2 |
BlackRock
New York
|
-$89.3M |
| 3 |
O
OrbiMed
New York
|
-$73.9M |
| 4 |
SG Americas Securities
New York
|
-$39.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.4M |
AGN.PRA Hedge Fund Activity: Q2 2017 in Review
109 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q2 2017, worth a combined $3.17B — up 8.9% from $2.91B a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AGN.PRA positions and 8 closed out — a net gain of 3 holders — while 32 added to existing stakes and 38 trimmed.
The largest buyer was Sculptor Capital, adding an estimated $86M. The largest seller was Loomis, Sayles & Company, cutting an estimated $175M.
- 109 institutional investors held Allergan plc (AGN.PRA) as of Q2 2017, up from 106 in Q1 2017.
- Funds reported $3.17B of Allergan plc stock for Q2 2017, up 8.9% quarter-over-quarter.
- 11 funds opened new Allergan plc positions in Q2 2017 and 8 closed out, a net change of +3 holders.
- The largest Allergan plc buyer in Q2 2017 was Sculptor Capital, an estimated $86M added.
- The largest Allergan plc seller in Q2 2017 was Loomis, Sayles & Company, an estimated $175M sold.
Based on aggregated 13F filings for Q2 2017.